Vera posts positive Phase 3 rare kidney disease data, but crowded market loomsnews2025-06-02T10:30:08+00:00June 2nd, 2025|Endpoints News|
FDA approves Moderna’s next-gen Covid vaccinenews2025-05-31T13:18:55+00:00May 31st, 2025|Endpoints News|
HHS loses bid to go ahead with firings, reorganizationnews2025-05-31T01:54:59+00:00May 31st, 2025|Endpoints News|
AstraZeneca agrees to pay $51M to settle ‘pay-for-delay’ class action suitnews2025-05-30T18:46:00+00:00May 30th, 2025|Endpoints News|
New CDC vaccine schedule at odds with HHS announcementnews2025-05-30T18:25:29+00:00May 30th, 2025|Endpoints News|
As a challenging first half nears a close, biopharma uncertainty persistsnews2025-05-30T13:46:12+00:00May 30th, 2025|Endpoints News|
#ASCO25: Pfizer’s Braftovi combo doubles survival time for some colorectal cancer patientsnews2025-05-30T12:00:22+00:00May 30th, 2025|Endpoints News|
US urges Supreme Court to decline Oklahoma PBM casenews2025-05-29T19:57:42+00:00May 29th, 2025|Endpoints News|
Eisai, Merck stave off generic competition to Lenvimanews2025-05-29T16:44:57+00:00May 29th, 2025|Endpoints News|
Big pharma companies explain why tariffs will harm US investments news2025-05-29T16:27:27+00:00May 29th, 2025|Endpoints News|
